Alliancebernstein L.P. Cyclerion Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$2.18 - $4.29 $69,324 - $136,422	-31,800 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$2.25 - $7.12 $4,995 - $15,806	-2,220 Reduced 6.53%	31,800 $97,000
Q3 2020 Nov 12, 2020	SELL	$3.46 - $8.39 $6,055 - $14,682	-1,750 Reduced 4.89%	34,020 $207,000
Q2 2020 Aug 13, 2020	BUY	$2.37 - $7.14 $17,571 - $52,935	7,414 Added 26.15%	35,770 $211,000
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $28,419 - $50,890	3,500 Added 14.08%	28,356 $344,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $238,617 - $567,959	24,856 New	24,856 $285,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $183M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.